Sophia Genetics SA

General ticker "SOPH" information:

  • Sector: Health Care
  • Industry: Health Care Technology
  • Capitalization: $219.6M

Sophia Genetics SA does not follow the US Stock Market performance with the rate: -39.1%.

Estimated limits based on current volatility of 2.6%: low 3.15$, high 3.32$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.15$, 7.35$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.39$, 7.76$]

Financial Metrics affecting the SOPH estimates:

  • Negative: Non-GAAP EPS, $ of -1.22 <= 0.10
  • Negative: Operating profit margin, % of -54.54 <= 1.03
  • Negative: Operating cash flow per share per price, % of -15.05 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -3.83 <= 3.85

Similar symbols

Short-term SOPH quotes

Long-term SOPH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $40.45MM $47.56MM $62.37MM
Operating Expenses $111.94MM $135.38MM $137.20MM
Operating Income $-71.49MM $-87.82MM $-74.83MM
Non-Operating Income $-2.02MM $0.24MM $-3.67MM
Interest Expense $0.66MM $0.64MM $0.59MM
R&D Expense $26.58MM $35.37MM $36.97MM
Income(Loss) $-73.51MM $-87.58MM $-78.50MM
Taxes $0.17MM $-0.14MM $0.49MM
Profit(Loss) $-73.67MM $-87.45MM $-78.98MM
Stockholders Equity $275.40MM $200.13MM $151.44MM
Inventory $5.73MM $5.16MM $6.48MM
Assets $320.17MM $243.84MM $206.16MM
Operating Cash Flow $-57.94MM $-70.09MM $-48.58MM
Capital expenditure $6.67MM $10.38MM $9.23MM
Investing Cash Flow $-56.93MM $41.97MM $8.32MM
Financing Cash Flow $237.77MM $-1.57MM $-2.82MM
Earnings Per Share* $-1.15 $-1.36 $-1.22

* EPS are Split Adjusted, recent splits may be reflected with a delay.